BI 894416
BI 894416 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated
Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma
A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood
Clinical Trials (6)
This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated
Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma
A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood
A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6